Expert Panel: Dr Parag k Shah,Dr Parijat Chandra, Dr Vasumathy V, Dr Ajay kapoor, Dr Syed Mohideen
1. Aflibercept: Current status in the Indian context - Dr Vasumathy V
2. Debate on aliquoting Avastin in private practice - Dr Ajay Kapoor (aliquot) vs Multipuncture - Dr Rekha Singal
3. Biosimilars in Ranibizumab: where do regulations and clinical evidence intersect - Dr Komal Agarwal
4. Re-injections - when exactly? Dr Alay Banker
5. Q &A: Audience cases if present / discussion
